{"disease":{"id":"verrucous-oral-leukoplakia","name":"verrucous oral leukoplakia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03603223","title":"Pembrolizumab in Treating Participants With Leukoplakia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":26,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}